TrialCancer science2017

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.

Nobuaki Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.